The White Horse Medical Practice has recently been granted special research status by the National Institute for Health Research. This has enabled the practice to undertake more studies in conjunction with Oxford University and many of our patients are currently involved.
The practice is actively involved in medical research and is always looking for patients to volunteer for the various clinical studies we are conducting. Some studies can be as simple as giving permission for the researchers to follow your medical progress by looking at your medical records. We always seek your fully informed consent and will be very happy to discuss with you the ins and outs of your involvement in the research.
If you want to find out more about what is involved in volunteering in clinical trials, you can click here.
If you are interested in being involved in more complicated research, we are currently running the following studies:
Asthma - The PALLADIUM Study is a trial of a new asthma inhaler which combines two existing asthma medications in a new compound and delivers it via a novel new device called the Concept 1 inhaler. Patients in this one year trial get lots of screening with ECGs, spirometry, blood tests and full physical examinations at regular intervals. If you have asthma that requires at least 3 different inhaled drugs (salbutamol and a combined inhaler such as seretide) and would like to help us with this study, please contact the surgery.
Atrial fibrillation - A huge thank you to all 21 patients with atrial fibrillation from our practice who have agreed to let us follow up their medical records for this important research. The National Thrombosis Institute now has over 50,000 patients on its GARFIELD database and will be able to compare the risk of stroke and major bleeding due to the different types of blood-thinning agents being used today. Five years ago there was only warfarin to prevent strokes in atrial fibrillation. Now there are at least five new drugs for the same problem but we don’t yet know which is best. This study will help us find out.
CCP - To determine if we can identify a population of anti-CCP Ab (+ve) patients by screening those patients with new onset, non-specific musculoskeletal complaints that would not be otherwise referred, or anyone with a first degree relative diagnosed with Rheumatoid Arthritis.
Conduct - Looking into the effectiveness and acceptability of two urine collection devices, aiming to reduce contaminated samples in women presenting with symptoms of a urinary tract infection.
The practice is also involved in some research to test new drugs. Usually these are substitutes for your existing medication to try and find out if the trial medication is better than existing treatment.
If you are interested in putting your name forward to be considered for these or future trials please contact Dr Simon Cartwright who is the research lead for the practice.